ABCL insider filings
AbCellera Biologics Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen ABCL transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings by 3 insiders — 122,778 shares, $1,366,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: purchase of 60,565 shares @ $11.54 ($698,920) by Thermopylae Holdings Ltd., filed 2026-11-12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Thermopylae Holdings Ltd. — 10% owner | 2 | 1 leg · 60,565 sh · $698,920 | — | 1 |
| Hayden Michael R — Director | 1 | 1 leg · 53,613 sh · $570,442 | — | — |
| Booth Andrew — Chief Financial Officer | 2 | 1 leg · 8,600 sh · $97,438 | — | 3 |
Recent insider filings — AbCellera Biologics Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Booth Andrew — Chief Financial Officer | Option exercise (M): 50,000 @ $0.32 · Gift (G): 50,000 @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-11-13 | 4 | Thermopylae Holdings Ltd. — 10% owner | Gift (G): 125,000 @ $0 | EDGAR |
| 2026-11-13 | 4 | Booth Andrew — Chief Financial Officer | Purchase (P): 8,600 @ $11.33 | EDGAR |
| 2026-11-12 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 60,565 @ $11.54 | EDGAR |
| 2026-08-24 | 4 | Hayden Michael R — Director | Purchase (P): 53,613 @ $10.64 | EDGAR |
| 2026-08-18 | 4 | Montalbano John S. — Director | Purchase (P): 10,000 @ $11.03 | EDGAR |
| 2026-08-14 | 4 | Booth Andrew — Chief Financial Officer | Purchase (P): 37,200 @ $10.32 | EDGAR |
| 2026-08-14 | 4 | Hayden Michael R — Director | Purchase (P): 46,387 @ $10.37 | EDGAR |
| 2026-08-13 | 4 | Hayden Michael R — Director | Gift (G): 50,000 @ $0 | EDGAR |
| 2026-07-06 | 4 | Sandor Victor — Director | Grant/award (A): 152,207 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Seely Lynn — Director | Grant/award (A): 152,207 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Montalbano John S. — Director | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Quake Stephen — Director | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Hayden Michael R — Director | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Booth Andrew — Chief Financial Officer | Option exercise (M): 250,000 @ $0.19 · Option exercise (M): 250,000 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Montalbano John S. — Director | Purchase (P): 20,000 @ $4.77 | EDGAR |
| 2026-03-02 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 38,000 @ $3.44 | EDGAR |
| 2026-02-27 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 177,457 @ $3.27 | EDGAR |
| 2026-02-27 | 4 | Booth Andrew — Chief Financial Officer | Purchase (P): 42,600 @ $3.42 | EDGAR |
| 2026-01-05 | 4 | Stimart Tryn — Chief Legal Officer | Grant/award (A): 539,265 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Lecault Veronique — Chief Technology Officer, Director | Grant/award (A): 539,265 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 2,106,505 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Booth Andrew — Chief Financial Officer | Grant/award (A): 808,898 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Thermopylae Holdings Ltd. — 10% owner | Gift (G): 225,000 @ $0 | EDGAR |
| 2025-12-19 | 4 | Quake Stephen — Director | Grant/award (A): 194,932 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Montalbano John S. — Director | Purchase (P): 50,000 @ $3.57 | EDGAR |
| 2025-07-01 | 4 | Hayden Michael R — Director | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Montalbano John S. — Director | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Lo Andrew — Director | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 343,631 @ $2.16 | EDGAR |
| 2025-03-10 | 4 | Montalbano John S. — Director | Purchase (P): 25,000 @ $2.30 | EDGAR |
| 2025-03-07 | 4 | Montalbano John S. — Director | Purchase (P): 60,000 @ $2.34 | EDGAR |
| 2025-01-03 | 4 | Stimart Tryn — Chief Legal Officer | Grant/award (A): 832,033 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Lecault Veronique — Chief Operating Officer, Director | Grant/award (A): 832,033 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Booth Andrew — Chief Financial Officer | Grant/award (A): 1,352,054 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 2,730,109 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | Thermopylae Holdings Ltd. — 10% owner | Gift (G): 286,000 @ $0 | EDGAR |
| 2024-11-26 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 283,516 @ $2.61 | EDGAR |
| 2024-06-24 | 4 | Lecault Veronique — Chief Operating Officer, Director | Option exercise (M): 83,334 @ $0.19 · Option exercise (M): 83,334 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Montalbano John S. — Director | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Lo Andrew — Director | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Hayden Michael R — Director | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Lecault Veronique — Chief Operating Officer, Director | Grant/award (A): 770,416 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Stimart Tryn — Chief Legal Officer | Grant/award (A): 616,333 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Booth Andrew — Chief Financial Officer | Grant/award (A): 770,416 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 2,095,532 (derivative) @ $0 | EDGAR |
Recent 8-K events — AbCellera Biologics Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ABCL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs